An Analytical Study of Selected Bulk Drug Manufacturers in Andhra Pradesh and Telangana: SEZ Status, Regulatory Framework, Compliance, Oversight, and Workforce Welfare and Safety
Abstract
Introduction: India’s bulk drug manufacturing industry has witnessed rapid growth over the past two decades, driven by supportive government policies, financial incentives, and regulatory reforms such as the Special Economic Zones (SEZ) Act 2005 and Rules 2006. Encouraged by these initiatives, several major pharmaceutical companies established manufacturing units across Andhra Pradesh and Telangana, particularly in industrial clusters and SEZs. Although this expansion significantly strengthened India’s pharmaceutical sector, it was also accompanied by multiple industrial accidents resulting in loss of lives and raising concerns about workplace safety and employee welfare.
Methods: This research paper evaluates ten selected bulk drug manufacturing companies using publicly available documents, regulatory reports, and media sources. The analysis is based on four key parameters: regulatory compliance, regulatory oversight, employee welfare, and workplace safety, along with a review of reported accidents.
Results and Discussion: The findings indicate that listed pharmaceutical companies generally perform better across all evaluated criteria. In contrast, certain SEZ-based unlisted companies, including Hetero SEZ Infrastructure and Escentia, appear to show weaker commitment toward employee welfare and occupational safety.
Summary: The study emphasizes the need for stricter regulatory enforcement, regular safety audits, greater transparency, and stronger accountability to ensure safer and more sustainable growth of the bulk drug manufacturing industry in India.
Conclusion: The review highlights the growth of India’s bulk drug industry and evaluates regulatory compliance, employee welfare, and workplace safety among selected companies. It emphasizes the need for stricter regulations, regular safety audits, transparency, and stronger accountability to ensure sustainable and safe industrial development.
Keywords:
Bulk drug manufacturers, SEZs, Regulations, Accidents, compliance, oversight, employee welfare, workplace safety
Downloads
Download data is not yet available.
References
1. Final Report, Survey of Pharma Clusters, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, Government of India, New Delhi, 2003 May.
2. Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. Guidelines for the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India. New Delhi: Government of India; 2020 Oct 29.
3. Guidelines of the Scheme "Promotion of Bulk Drug Parks", Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals; 27th July, 2020
4. Indian Bulk Drug Industry: Regaining Lost Glory. [Internet]. New Delhi: Confederation of Indian Industry (CII); 2017 [cited 2025 Nov 11]. Available from: https://ciipharma.in/pdf/API-Report-2017.pdf
5. Indian API Industry: Reaching the Full Potential. [Internet]. New Delhi: Confederation of Indian Industry (CII); 2020 [cited 2025 Nov 04]. Available from: https://www.medicpresents.com/medicfiles/4d15_65793.indianapiindustryreachingthefullpotentialkpmgciithoughtleadershipreport2020.pdf
6. Sandhu G. Making India self-sufficient. Express Pharma [Internet]. Mumbai: Express Pharma; 2020 Aug 28 [cited 2025 Oct 25]. Available from:
https://www.expresspharma.in/making-india-self-sufficient/
7. Shefali Singh and Harvinder Popli, Indian Active Pharmaceutical Ingredient (API) Industry—An overview on Challenges, Opportunities and Regulatory prerequisites. International Journal of Drug Regulatory Affairs, 2021; 9(2):66–76.
8. Salient Features of the recommendations of the Katoch committee Report on Active Pharmaceuticals Ingredients (APIs), Ministry of Chemicals and Fertilizers Department of Pharmaceuticals, New Delhi; 24th September, 2015.
9. The Special Economic Zones Act, 2005 (Act No. 28 of 2005), Amended upto April 2024, Export Promotion Council for EOUs and SEZs, Ministry of Commerce and Industry[Internet]. Government of India, New Delhi, 2005 [cited 2025 Nov 04]. Available from:
https://epces.in/uploads/the-special-economic-act-text.pdf.
10. Government of India. The Special Economic Zones Rules, 2006 [Internet]. New Delhi: Ministry of Commerce and Industry, 2006 [cited 2025 Nov 04]. Available from:
https://epces.in/uploads/the-special-economic-zones-rules-text.pdf,
11. Policy framework for Special Economic Zones (SEZs) in Andhra Pradesh, Industries and Commerce Department; G.O.Ms.No.151;2002. Apr 09.
12. Labour Department – Ease of doing business – Introduction of online inspection system, Government of Andhra Pradesh, Abstract; 2016 May 31.
13. Online Consent Management and Monitoring System[Internet]. MEFCC, Government of India [cited 2025 Oct 26]. Available from:
https://ocmms.nic.in/OCMMS_NEW/
14. Andhra Pradesh Pollution Control Board (APPCB). Online Consent Management and Monitoring System (OCMMS) Portal [Internet]. Vijayawada: APPCB; [cited 2025 Oct 25]. Available from: https://apocmms.nic.in/APPCB/
15. The Andhra Pradesh Single Desk Policy 2015 – Modified Policy - GOVERNMENT OF ANDHRA PRADESH ABSTRACT; 2016 Jun 14.
16. Industrial Policy Framework for the State of Telangana, Industries and Commerce Department [Internet]. Government of Telangana; 2014 [cited 2025 Oct 27]. Available from:
https://startup.telangana.gov.in/wp-content/uploads/2025/02/Industrial-Framework-2014-Version-1-1.pdf.
17. Industrial Policy Framework For The State of Telangana[Internet]. [cited 2025 Oct 27]. Available from:
https://www.tgiic.telangana.gov.in/filePreview/custom/Industrail%20policy%20Framework%20for%20the%20state?fileName=CMS/File_080720241203051120401271.Industrail%20policy%20Framework%20for%20the%20state.pdf
18. The Telangana State Industrial Project Approval and Self Certification System (TS iPASS) Act,2014 [Internet]. Act3 of 2014[cited 2025 Oct 27]. Available from:
https://www.casemine.com/act/in/5ed4fb14894ef23297d8bdf5.
19. Labour, Employment, Training and Factories Department – Inspections under various Labour Laws to facilitate Ease of Doing Business in the State, LABOUR EMPLOYMENT TRAINING and FACTORIES (LABOUR) DEPARTMENT G.O.Ms. No. 7; 2017 Apr 21.
20. Industrial and Commerce Department- Ease of Doing Business (EODB)-Business Reform Action Plan -2017-Central inspection system – orders- issued, INDUSTRIES and COMMERCE (IP and INF) DEPARMENT G.O.Ms.No. 45 1; 2017 Jul20.
21. Telangana Pollution Control Board[Internet]. [cited 2025 Oct 27]. Available from:
https://tgpcb.cgg.gov.in/?menuid=1001,
22. Central Pollution Control Board (CPCB). National OCMMS Dashboard Listing State Pollution Control Board Online Consent Portals, New Delhi: CPCB. [Cited 2025 Oct 27]. Available from: https://cpcb.nic.in/.,
23. Driving Sustainable Growth,AurobindoPharma Ltd. Integrated Annual Report 2023–24: Hyderabad: Aurobindo Pharma Ltd; 2024. p. 230.
24. Aurobindo Pharma Ltd. Business Responsibility and Sustainability Report for FY 2023–24. Mumbai: Submitted to National Stock Exchange of India Ltd; 2024. p. 5, 16–18, 26–27.
25. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation to M/s Aurobindo Pharma Ltd, Unit XIV, Plot No 17 E, Bonangi Village, JN Pharma City, Parawada, Visakhapatnam Dist, Andhra Pradesh 531019 (7-5/2013/EU/WC-0461), 2023 Sep 18.
26. Government of India, MoEF, Environmental Clearance No. J-12011/1/2004-IA (CIE), MoEF; 2005 Mar 10.
27. CDSCO WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in Various States – List for Andhra Pradesh (No. 51), CDSCO; 2022 Dec.
28. USFDA Inspection Report – Aurobindo Pharma Ltd Unit XIV Anakapalli Dist Andhra Pradesh; 2023 Jul 18. Silver Spring (MD): USFDA; 2023.
29. Aurobindo Pharma Ltd. Completion of US FDA Inspection at Unit XIV – Intimation to National Stock Exchange of India Ltd; 2023 May 19. Hyderabad: Aurobindo Pharma Ltd; 2023.
30. CPCB, Directions under Section 5 of the Environment (Protection) Act 1986 – Show-Cause Notice to M/s Aurobindo Pharma Ltd Unit XIV Plot No 17A JN Pharma City Parawada Visakhapatnam AP; 2021 Jun 22. New Delhi: CPCB; 2021.
31. Aurobindo Pharma Ltd. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 – Intimation regarding Workplace safety Accident on 6 Apr 2024 at Unit 6 of Apitoria Pharma Pvt Ltd (Wholly Owned Subsidiary). Hyderabad: Aurobindo Pharma Ltd; 2024 Apr 7.
32. The Times of India. Gas leak explosion in pharma units: 2 dead, 6 injured [Internet]. New Delhi: The Times of India; 2024 Apr 08 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/gas-leak-explosion-in-pharma-units-2-died-6-injured/articleshow/109116029.cms
33. The Hindu. Apitoria Pharma hikes workers’ wages [Internet]. Chennai: The Hindu; 2024 Jun 27 [cited 2025 Oct 27]. Available from:
https://www.thehindu.com/news/national/andhra-pradesh/apitoria-pharma-limited-hikes-workers-wages/article68340274.ece
34. Impacts of Pharmaceutical Pollution on Communities and Environment in India [Internet]. London: Changing Markets Foundation and Ecostorm; [cited 2025 Oct 27]. Available from:
https://changingmarkets.org/report/impacts-of-pharmaceutical-pollution-on-communities-and-environment-in-india/
35. Hyderabad’s Pharmaceutical Pollution Crisis [Internet]. London: Changing Markets Foundation; 2018 Jan [cited 2025 Oct 27]. Available from:
https://changingmarkets.org/report/hyderabads-pharmaceutical-pollution-crisis/
36. Annual Report 2022–23, Gland Pharma Ltd.: Strengthening Our Core amid Challenges. Hyderabad: Gland Pharma Ltd; 2023.
37. Annual Report 2021–22: Manufacturing Excellence – Robust R and D – Quality First – Best-in-Class Products – Regulatory Compliance Gland Pharma Ltd. Hyderabad: Gland Pharma Ltd; 2022.
38. Gland Pharma Ltd. Business Responsibility and Sustainability Report 2023–24 [Internet]. Hyderabad: Gland Pharma Ltd; 2024 [cited 2025 Nov 04]. Available from: https://glandpharma.com/images/BRSR%20FY%202023-24.pdf
39. Gland Pharma facility in Vizag receives EIR from US FDA [Internet]. Chennai: The Hindu; [cited 2025 Oct 27]. Available from: https://www.thehindu.com/business/gland-pharma-facility-in-vizag-recieves-eir-from-us-fda/article69731760.ece
40. WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in various states of India [Internet]. New Delhi: CDSCO; 2019 May [cited 2025 Oct 27]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadIndustryCommon/listwhogmp.pdf
41. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation 7-5/12018/EU/WC-0427 to M/s Gland Pharma Ltd Plot Nos 49 and 50 JN Pharma City Parawada Visakhapatnam 531019 AP; 2023 Jun 22. New Delhi: CDSCO; 2023.
42. Government of India, MoEFC Environmental Clearance F. No. J-11011/265/2015-IA II (1). New Delhi: MoEFCC; 2019 Jan 2.
43. CONDITION-WISE COMPLIANCE REPORT OF ENVIRONMENTAL CLEARANCE MoEF, Govt. of India EC Order No.: J-11011/265/2015-IA II (I), dated 02-01-2019
44. Andhra Pradesh Pollution Control Board (APPCB). Consent Order No. APPCB/VIA/VIA/14347/HO/CFO/ 2019 [Internet]. Vijayawada: APPCB; 2019 Sep 17 [cited 2025 Nov 06]. Available from:
https://pcb.ap.gov.in/APPCBDOCS/Tenders_Noti/7.%20DS%20-%20Amendment%20-%20Porus%20Laboratories%20Pvt%20Ltd,%20Unit%20%E2%80%93%20IV,%20Krishna%20District.pdf
45. Porus Laboratories Pvt Ltd. Proposed Expansion of APIs and API Intermediates Manufacturing Unit with 3 MW Captive Power Plant at Akkireddigudem (MusunuruMandal), Plan dated 2016 Jan 25. Eluru: Porus Labs; 2016.
46. Porus Laboratories Pvt Ltd. Proposed Expansion Project of Active Pharmaceutical Ingredients and API Intermediates Manufacturing Unit with R and D Facility and 3 MW Coal/Husk/Pellet-Fired Captive Power Plant at Akkireddigudem (V), Musunuru (M), Krishna Dist; 2018 Mar 13. Eluru: Porus Labs; 2018.
47. Porus Laboratories Pvt Ltd. Risk Assessment Report Part B – Chapter 7 of EIA Report (Unit IV). Eluru: Porus Labs; 2018.
48. NGT Judgment on Porus Labs Accident (CaseMine Digest) [Internet]. New Delhi: National Green Tribunal Southern Zone; 2022 Sep 21 [cited 2025 Nov 06]. Available from: https://www.legitquest.com/case/aryavart-foundation-v-porus-laboratories-private-limited/739401
49. Muttevi S. Porus Labs was a ticking time bomb for Akkireddygudem village. The New Indian Express [Internet]. Chennai: The New Indian Express; 2022 Apr 18 [cited 2025 Oct 22]. Available from: [insert URL]
50. NGT slaps Rs 29 lakh penalty on Porus Labs [Internet]. Chennai: The New Indian Express; 2022 Sep 25 [cited 2025 Nov 11]. Available from: https://www.newindianexpress.com/states/andhra-pradesh/2022/Sep/24/ngt-slaps-rs-29-lakh-penalty-on-porus-labs-2501694.html
51. Pandey A. Porus Lab in Andhra Pradesh shut after six workers died in fire accident [Internet]. Noida: India Today; 2022 Apr 15 [cited 2025 Oct 27]. Available from: https://www.indiatoday.in/india/story/andhra-pradesh-pollution-control-board-shut-down-porus-lab-after-workers-died-fire-accident-1937717-2022-04-15
52. World Health Organization. Prequalification Unit – Public Inspection Report (WHOPIR): Desk Assessment of API Manufacturer, Hetero Infrastructure SEZ Ltd, Unit IX [Internet]. Geneva: WHO; [cited 2025 Oct 27]. Available from:
https://extranet.who.int/prequal/medicines/ha696
53. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation to M/s Hetero Drugs Ltd (Unit IX) Plot No 1 Hetero Infrastructure SEZ Ltd N. Narasapuram Village Nakkapalli Mandal Visakhapatnam Dist (AP) 75/2013/EU/WC-0066; 2019 Sep 3. New Delhi: CDSCO; 2019.
54. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation 7-5/2013/EU/WC-0065 to M/s Hetero Labs Ltd (Unit IX) Plot No 2 Hetero Infrastructure SEZ Ltd N. Narasapuram Village Nakkapalli Mandal Anakapalli Dist AP 531081; 2023 Jun 23. New Delhi: CDSCO; 2023.
55. Hetero Drugs Ltd. Compliance report of Environmental Clearance from Hetero Drugs Ltd Unit VI [Internet]. Hyderabad: Hetero Drugs Ltd; 2012 Sep 10 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HDL-VI_EC_Compliance_June_status_report.pdf
56. Hetero Labs Ltd. Environment Clearance No. J-11011/398/2010-IA-II dated 2012 Sep 10 – Compliance report [Internet]. Hyderabad: Hetero Labs Ltd; 2022 Dec 29 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HDL-VI-EC-Compliance-2022.pdf
57. Hetero Labs Ltd. Environment Clearance No. J-11011/398/2010-IA-II dated 2012 Sep 10 – Compliance report [Internet]. Hyderabad: Hetero Labs Ltd; 2023 May 13 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HLL-III(HDL-VI)-EC-Compliance-June2024.pdf
58. Hetero Labs. The Promise of a Healthier World: Sustainability Report 2020–21 [Internet]. Hyderabad: Hetero Labs; 2021 [cited 2025 Oct 27]. Available from:
https://www.hetero.com/pdf/Hetero_Sustainability_Report_%28202021%29.pdf
59. Hetero Labs. Fostering Sustainability for Posterity: Sustainability Report 2021–22 [Internet]. Hyderabad: Hetero Labs; 2022 [cited 2025 Oct 27]. Available from:
https://www.hetero.com/pdf/Hetero%20%20Sustainability%20Report%20%282021-22%29%20-%205%20May%2023%20%28web%20version%29.pdf
60. Hetero Labs Ltd. Six-Monthly Compliance Report Submitted to Ministry of Environment Forest and Climate Change, Vijayawada; 2023 Dec 1. Vijayawada: Hetero Labs; 2023.
61. Hetero Labs Ltd. Certified Third-Party Six-Monthly Compliance Report for Environmental Clearance No. J-11011/396/2010-IA II (I) dated 2012 Sep 10; submitted to MoEFCC Chennai; 2022 Jan 20. 2022.
62. Another disaster in Andhra raises fresh questions on industrial safety [Internet]. Mumbai: Business Standard; 2022 Apr 14 [cited 2025 Nov 11]. Available from:
https://www.business-standard.com/article/current-affairs/another-disaster-in-andhra-raises-fresh-questions-on-industrial-safety-122041400917_1.html
63. Blast at Hetero Drugs Nakkapalli kills two [Internet]. New Delhi: Business Today; 2013 Jan 05 [cited 2025 Oct 27]. Available from:
https://www.businesstoday.in/latest/corporate/story/blast-at-hetero-drugs-nakkapalli-unit-two-killed-39312-2013-01-05
64. Hetero Drugs DGM held for blast [Internet]. New Delhi: The Times of India; 2013 Mar [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/hetero-drugs-dgm-held-for-reactor-blast/articleshow/18757091.cms
65. One worker killed in explosion at Hetero Drugs scrap yard [Internet]. Chennai: The New Indian Express; 2016 Jun 23 [cited 2025 Oct 27]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2016/Jun/22/one-worker-killed-in-explosion-at-hetero-drugs-scrap-yard-884018.html
66. Visakhapatnam: Two employees seriously injured in Hetero Pharma blast [Internet]. New Delhi: The Times of India; 2022 Feb 23 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/visakhapatnam-two-employees-seriously-injured-in-hetero-pharma-blast/articleshow/89781623.cms
67. MD Bureau. One dies in Hetero Visakhapatnam Plant Blast [Internet]. New Delhi: Medical Dialogues; 2022 Feb 25 [cited 2025 Oct 27]. Available from:
https://medicaldialogues.in/news/industry/pharma/one-dies-in-hetero-visakhapatnam-plant-blast-89134
68. Anakapalli: 12 workers hospitalised after toxic gas leak at Hetero Pharma [Internet]. New Delhi: The Times of India; 2025 Feb 05 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/vijayawada/12-workers-hospitalized-after-inhaling-fumes-in-a-pharma-company-in-andhra-pradeshs-anakapalle/articleshow/117931598.cms
69. Government of India, Ministry of Environment, Forest and Climate Change. Reply affidavit on behalf of MoEFCC before the National Green Tribunal Southern Zone Bench, Chennai [Internet]. New Delhi: MoEFCC; 2023 [cited 2025 Oct 27]. Available from:
https://www.greentribunal.gov.in/sites/default/files/news_updates/OA%2023%20of%202022%20Response%20by%20R11.pdf
70. CDSCO (International Cell). Written Confirmation No. 7-5/2021/EU/WC-0501 dated 2022 Jun 15 [Internet]. New Delhi: CDSCO; 2022 [cited 2025 Oct 27]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadInternationalCell/WC%20-0094%20-Hikal%20%282%29.pdf
71. CDSCO (International Cell). Written Confirmation No. 7-5/2021/EU/WC-0501 dated 2024 May 16 [Internet]. New Delhi: CDSCO; 2024 [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadInternationalCell/WC%20-0501%20-Escientia.pdf
72. US Food and Drug Administration (USFDA). Drug Establishments Current Registration Site – Facilities List (as of April 30, 2024) [Internet]. Silver Spring (MD): USFDA; 2024 Apr 30 [cited 2025 Oct 27]. Available from:
https://www.fda.gov/media/178556/download
73. Government of India, Ministry of Environment and Forests. Environmental Clearance F. No. 21-379/2007-IA III for Multi-product Andhra Pradesh Special Economic Zone (APSEZ) [Internet]. New Delhi: MoEF; 2012 Feb 13 [cited 2025 Oct 27]. Available from:
https://environmentclearance.nic.in/
74. Government of Andhra Pradesh. Initial Environmental Examination for Asian Development Bank (ADB) Projects [Internet]. Amaravati: Government of Andhra Pradesh; 2022 Dec [cited 2025 Oct 28]. Available from:
https://ewsdata.rightsindevelopment.org/files/documents/04/ADB-48434-004_9wZhbBp.pdf
75. Andhra Pradesh Pollution Control Board (APPCB). Consent to Operate (CTO), File No. APPCB-11022/182/2018-TEC-CFO-APPCB [Internet]. Vijayawada: APPCB; 2024 Jan 09 [cited 2025 Oct 28]. Available from:
https://www.ocmms.nic.in/OCMMS_NEW/download.action
76. US Food and Drug Administration (USFDA). Establishment inspection record—Escentia; status: NAI (No Action Indicated) [Internet]. Silver Spring (MD): USFDA; 2019 Aug 11 [cited 2025 Oct 28]. Available from:
https://hbw.citeline.com/-/media/supporting-documents/pink-sheet/2021/02/fda-drug-quality-inspections-fy-2020.pdf
77. Explosion claims 17 lives in Atchutapuram SEZ [Internet]. Vijayawada: The Pioneer; 2024 Aug 22 [cited 2025 Oct 27]. Available from:
https://www.dailypioneer.com/uploads/2024/epaper/august/vijayawada-english-edition-2024-08-22.pdf
78. Explosion at Andhra factory that killed 17 caused by inflammable solvent leakage [Internet]. New Delhi: Hindustan Times; 2024 Aug 22 [cited 2025 Nov 11]. Available from:
https://www.hindustantimes.com/india-news/explosion-at-andhra-factory-which-killed-17-caused-by-inflammable-solvent-leakage-101724331154090.html
79. Bhattachargee S. AP pharma unit blast: Officials find key design faults in plant [Internet]. Chennai: The Hindu; 2024 Aug 24 [cited 2025 Oct 28]. Available from:
https://www.thehindu.com/news/cities/Visakhapatnam/ap-pharma-unit-blast-officials-find-key-design-faults-in-plant/article68562041.ece
80. Raghavendra V. High-level committee report on accident at pharma company in Anakapalli district ‘deficient’, allege retired scientists [Internet]. Vijayawada: The Hindu; 2025 Mar 24 [cited 2025 Oct 28]. Available from:
https://www.thehindu.com/news/national/andhra-pradesh/high-level-committee-report-on-accident-at-pharma-company-in-anakapalli-district-deficient-allege-retired-scientists/article69369348.ece
81. Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. Rajya Sabha Unstarred Question No. 315 answered on 2025 Jul 22 [Internet]. New Delhi: Government of India; 2025 Jul 22 [cited 2025 Oct 28]. Available from:
https://sansad.in/getFile/annex/268/AU315_UCXCGY.pdf
82. Central Pollution Control Board (CPCB). National Inventory on Generation and Management of Hazardous and Other Wastes (2022–23) [Internet]. New Delhi: CPCB; 2024 May [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/uploads/hwmd/Annual_Inventory2022-23.pdf
83. Central Pollution Control Board (CPCB). National Inventory on Generation and Management of Hazardous and Other Wastes (2023–24) [Internet]. New Delhi: CPCB; 2025 Apr [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/uploads/hwmd/Annual_Inventory2023-24.pdf
84. Siva G. Safety audit was done at Sahithi Pharma in April [Internet]. New Delhi: The Times of India; 2023 Jul 02 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/safety-audit-was-done-at-sahithi-pharma-in-april/articleshow/101427015.cms
85. Five-member panel probes pharma unit blast in Andhra [Internet]. Chennai: The New Indian Express; 2023 Jul 02 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/andhra-pradesh/2023/Jul/02/five-member-panel-probes-pharma-unit-blast-in-andhra-2590617.html
86. Probe panel says non-technical staff was Sahiti unit in-charge [Internet]. Chennai: The New Indian Express; 2023 Jul 25 [cited 2025 Nov 02]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2023/Jul/25/probe-panel-says-non-technical-staff-was-sahiti-unit-in-charge-2598267.html
87. Andhra Pradesh Pollution Control Board (APPCB). Report filed before the Hon’ble National Green Tribunal, Southern Zone, Chennai—NGT stop order to Sahithi [Internet]. Vijayawada: APPCB; 2023 Aug 01 [cited 2025 Oct 28]. Available from:
https://www.scribd.com/document/697921812/8923-0
88. Kin of AP blast victims seek compensation [Internet]. Chennai: The New Indian Express; 2023 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/business/2023/Jul/01/kin-of-ap-blast-victims-seek-compensation-from-pharmaceutical-company-2590422.html
89. Rao GJ. Safety audit was done in 186 hazardous units of Andhra [Internet]. Chennai: The New Indian Express; 2023 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2023/Jul/01/safety-audit-done-in-186-hazardous-units-of-andhra-2590338.html
90. Samritan SG. Vizag to get off-site emergency plan amid industrial risks [Internet]. Hyderabad: Deccan Chronicle; 2024 Aug 29 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/southern-states/andhra-pradesh/vizag-to-get-off-site-emergency-plan-amid-industrial-risks-1819831
91. Andhra Pradesh Pollution Control Board (APPCB). Consent to Establish (CTE) Order No. 193/APPCB/CTE/RO-VSP/HO/2009, File No. 193/APPCB/CFE/RO-VSP/HO/2014 [Internet]. Vijayawada: APPCB; 2023 Mar 31 [cited 2025 Oct 28]. Available from:
https://ocmms.nic.in/OCMMS_NEW/download.action
92. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation No. 7-5/2016/EU/WC-0371 to M/s Sainor Life Sciences Pvt Ltd [Internet]. New Delhi: CDSCO; 2019 Oct 28 [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadAlertsFiles/23janUpdated%20Approved%20WC.pdf
93. WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in various states of India [Internet]. New Delhi: CDSCO; 2022 Dec [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadIndustryCommon/22WHO%20GMP%20CoPP%20units.pdf
94. Andhra Pradesh Pollution Control Board (APPCB).Consent and Authorization Order, Consent Order No. 7223/ APPCB/ ZO-VSP/ VSP/ CFO/ 2020. Visakhapatnam: APPCB (Zonal Office); 2020 Sep 23.
95. Two dead, five injured in blast at Sainor Life Sciences unit [Internet]. New Delhi: The Times of India; 2015 Sep 29 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/2-dead-5-injured-in-blast-at-sainor-life-sciences-unit/articleshow/49147773.cms
96. Vizag pharma unit where gas leak killed two saw similar tragedy in 2015 [Internet]. Chennai: The News Minute; 2020 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.thenewsminute.com/andhra-pradesh/vizag-pharma-unit-where-gas-leak-killed-two-saw-similar-tragedy-2015-127685
97. Joint Committee (NGT matter). Report of the Joint Committee submitted to the National Green Tribunal [Internet]. 2020 Jul 06 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/NGT/REPORT2-31.12.2020.pdf
98. Ministry of Environment, Forest and Climate Change (India). NGT directs that safety audits be conducted for the pharma city in Visakhapatnam along with other locations in the State. Environmental Law Newsletter [Internet]. 2020 Dec;1(4) [cited 2025 Oct 28]. Available from:
https://www.amsshardul.com/wp-content/uploads/2021/01/Environmental-Law-Newsletter-%E2%80%93-Issue-4.pdf
99. District Collector, Visakhapatnam. Report on gas leakage at Sainor Life Sciences, JN Pharmacity, Visakhapatnam [Internet]. Visakhapatnam: District Collectorate; [cited 2025 Oct 28]. Available from:
https://telugu.samayam.com/andhra-pradesh/news/vizag-collector-press-meet-on-sainor-life-sciences-factory-gas-leak-tragedy/articleshow/76770622.cms
100. Swedish report slams polluting pharma firms of Hyderabad, Vizag [Internet]. Hyderabad: Deccan Chronicle; 2016 Apr 20 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/current-affairs/200416/swedish-report-slams-polluting-pharma-firms-from-hyderabad-vizag.html
101. Human Rights Forum (HRF). Vizag Pharma City: A virtual death zone [Internet]. Hyderabad: HRF; 2020 Jun 30 [cited 2025 Oct 28]. Available from:
https://humanrightsforum.org/vizag-pharma-city-a-virtual-death-zone/
102. Accident at Sainor unit in Vizag more proof of companies bypassing rules [Internet]. New Delhi: Down To Earth; 2020 Jul 09 [cited 2025 Oct 28]. Available from:
https://www.downtoearth.org.in/pollution/accident-at-sainor-unit-in-vizag-more-proof-of-companies-bypassing-rules-72214
103. Synergene Active Ingredients Pvt Ltd. Infrastructure and regulatory—capacity 380 KL; employees 250; WHO-GMP, ISO 9001/14001/45001 [Internet]. Visakhapatnam: Synergene Active Ingredients Pvt Ltd; [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/infrastructure-and-regulatory/
104. Andhra Pradesh Pollution Control Board (APPCB). Consent Order No. APPCB/VSP/VSP/423/HO/CFO/2019; File No. APPCB-11022/64/2019-TEC-CFO-APPCB [Internet]. Vijayawada: APPCB; 2019 May 12 [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2021/03/unit-III-CFO.pdf
105. Andhra Pradesh Pollution Control Board (APPCB). Red Category Consent to Operate and Hazardous Waste Authorization Order, Consent Order No. APPCB/VSP/VSP/423/HO/CFO/2024 [Internet]. Vijayawada: APPCB; 2024 Jun 05 [cited 2025 Oct 28]. Available from:
https://ocmms.nic.in/OCMMS_NEW/download.action
106. Drugs Control Administration, Government of Andhra Pradesh. Good Manufacturing Practices and Good Laboratory Practices Certificate to M/s Synergene Active Ingredients Pvt Ltd, Unit III [Internet]. Visakhapatnam: Drugs Control Administration; 2025 Jan 29 [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2025/03/U-III-GMP-CERTIFICATE.pdf
107. Synergene Active Ingredients Pvt Ltd. Proposal to establish bulk drugs and intermediates manufacturing unit at Plot No. 59-A, JN Pharmacity, Parawada Mandal, Visakhapatnam District, Andhra Pradesh [Internet]. Visakhapatnam: Synergene Active Ingredients Pvt Ltd; [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2021/03/unit-III-EMP.pdf
108. Fire erupts at pharmacy unit in Andhra’s Anakapalle; four hurt [Internet]. Chennai: The New Indian Express; 2024 Aug 23 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2024/Aug/23/four-injured-in-fire-mishap-at-pharma-factory-in-ap-2
109. Andhra Pradesh: Toll rises to three in Parwada pharma unit fire accident [Internet]. Hyderabad: Telangana Today; 2024 Aug 26 [cited 2025 Nov 11]. Available from:
https://telanganatoday.com/andhra-pradesh-toll-rises-to-three-in-parwada-pharma-unit-fire-accident
110. Nalla Babu. Pharma mishap: 2 more workers succumb, toll rises to three [Internet]. New Delhi: The Times of India; 2024 Aug 27 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/pharma-mishap-death-toll-rises-to-three-in-visakhapatnam/articleshow/112819858.cms
111. World Health Organization (WHO). Public Inspection Report: Laurus Labs Limited, Unit 3, Visakhapatnam, India (4–7 September 2017) [Internet]. Geneva: WHO; 2017 [cited 2025 Oct 28]. Available from:
https://extranet.who.int/prequal/sites/default/files/whopir_files/WHOPIR_Laurus04-07September2017.pdf
112. Laurus Labs Ltd. Creating Value, Sustaining Trust—Integrated Report 2021 [Internet]. Hyderabad: Laurus Labs Ltd; 2021 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/images/pdfs/LaurusIntegratedReport.pdf
113. Laurus Labs Ltd. Enhancing Capabilities Ensuring Future: Annual Report 2022–23 [Internet]. Hyderabad: Laurus Labs Ltd; 2023 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/pdf/LaurusLabsAnnualReportFY2022-23.pdf
114. Consent for Establishment (CFE) Order No. 331/APPCB/CFE/RO-VSP/HO/2014 Andhra Pradesh Pollution Control Board (26 Dec 2019).
115. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation F. No. 7-5/2017/EU/WC-0395—Pharma City, Parawada (M), Visakhapatnam 531021, Andhra Pradesh. New Delhi: CDSCO; 2019 Mar 5.
116. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit 3), Plot No. 18, JN Pharmacity, Parawada, Visakhapatnam 531021, Andhra Pradesh; 75/2017/EU/WC-0395. New Delhi: CDSCO; 2020 Dec 4.
117. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit 3), Plot No. 18, JN Pharmacity, Parawada, Visakhapatnam 531021, Andhra Pradesh; 7-5/2017/EU/WC-0395. New Delhi: CDSCO; 2022 Aug 1.
118. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit-III), Plot No. 18, JN Pharmacity, ParawadaMandal, Anakapalli District 531021, Andhra Pradesh; 7-5/2017/EU/WC-0395. New Delhi: CDSCO; 2024 Apr 8.
119. World Health Organization (WHO). Prequalification Unit—Public Inspection Report (WHOPIR): Desk Assessment of Active Pharmaceutical Ingredient (API) Manufacturer. Geneva: WHO; 2020 Jun 3.
120. Laurus Labs Ltd. Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015—EIR received. Hyderabad: Laurus Labs Ltd; [year unknown].
121. Laurus Labs Ltd. Business Responsibility and Sustainability Report—Annual Report 2023–24 [Internet]. Hyderabad: Laurus Labs Ltd; 2024 [cited 2025 Oct 28]. Available from:
https://nsearchives.nseindia.com/corporate/LAURUSLABS_01102024194544_BRSR2024.pdf
122. Laurus Labs Ltd. Fulfilling Our Commitment to Global Wellbeing [Internet]. Hyderabad: Laurus Labs Ltd; [cited 2025 Oct 28]. Available from: https://lauruslabs.com/
123. Deccan Chronicle. Four dead, one hurt in Vizag Pharma City fire mishap [Internet]. Hyderabad: Deccan Chronicle; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/in-other-news/261222/4-dead-one-hurtin-vizag-pharma-city-fire-mishap.html
124. Laurus Labs Ltd. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 [Internet]. Mumbai: BSE Ltd; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/Investors/PDF/Disclosures/SEIntimation.pdf
125. Deccan Chronicle. Four dead, one hurt in Vizag Pharma City fire mishap [Internet]. Hyderabad: Deccan Chronicle; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/in-other-news/261222/4-dead-one-hurtin-vizag-pharma-city-fire-mishap.html
126. Reuters. India’s Laurus Labs says four employees died in fire incident [Internet]. London: Reuters; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.reuters.com/world/india/indias-laurus-labs-says-four-employees-dead-after-fire-incident-2022-12-27/
127. Telangana State Pollution Control Board (TSPCB). List of industries under consent management in Medak District [Internet]. Hyderabad: TSPCB; [cited 2025 Oct 28]. Available from:
https://tgpcb.cgg.gov.in/Uploads/AboutUs/Sangareddy.pdf
128. State Environment Impact Assessment Authority (SEIAA), Telangana. Proceedings of the 91st SEIAA Meeting [Internet]. Hyderabad: SEIAA Telangana; 2020 Dec 17 [cited 2025 Oct 28]. Available from:
https://environmentclearance.nic.in/report/minutes_meeting_report_b.aspx?state_id=38
129. SB Organics Ltd. Proposal for production of intermediates [Internet]. Hyderabad: SB Organics Ltd; [cited 2025 Oct 28]. Available from:
https://environmentclearance.nic.in/DownloadPfdFile.aspx
130. Business Standard. Explosion at Telangana pharma plant kills director, three workers; 16 injured [Internet]. Mumbai: Business Standard; 2024 Apr 03 [cited 2025 Oct 28]. Available from:
https://www.business-standard.com/india-news/explosion-at-telangana-pharma-plant-kills-director-3-workers-16-injured-124040301207_1.html
131. Deccan Chronicle. Telangana: Panel slams SBOL firm for deadly blast [Internet]. Hyderabad: Deccan Chronicle; 2024 Jul 21 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/southern-states/telangana-panel-slams-sbol-firm-for-deadly-blast-1811419
132. Three months on, pharma unit blast probe still in limbo [Internet]. New Delhi: The Times of India; 2024 Jul 22 [cited 2025 Nov 11]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/3-months-on-pharma-unit-blast-probe-still-in-limbo/articleshow/111911195.cms
133. The Times of India. Lack of workplace safety norms, PCB nod to blame for pharma unit blast [Internet]. New Delhi: The Times of India; 2024 Apr 27 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/lack-of-safety-norms-pcb-nod-to-blame-for-pharma-unit-blast/articleshow/109636982.cms
134. The Economic Times. PCB levies Rs 31 lakh penalty on pharma manufacturing unit over violations [Internet]. Mumbai: The Economic Times; 2024 Dec 10 [cited 2025 Oct 28]. Available from:
https://manufacturing.economictimes.indiatimes.com/amp/news/life-sciences/pcb-levies-rs-31-lakh-penalty-on-pharma-manufacturing-unit-over-violations/116158889
135. Before the National Green Tribunal, Southern Zone, Chennai. Case order [Internet]. Chennai: National Green Tribunal; 2025 Feb 12 [cited 2025 Oct 28]. Available from: CaseMine database.
136. Government of India, Ministry of Health and Family Welfare. Lok Sabha Unstarred Question No. 2226 answered on 2025 Aug 1. New Delhi: Government of India; 2025 Aug 1.
137. Government of India, Ministry of Labour and Employment. Lok Sabha Unstarred Question No. 2416 to be answered on 2025 Aug 4. New Delhi: Government of India; 2025 Aug 4.
138. The News Minute. AP: Industries find it easier to pay compensation than implement safety protocols [Internet]. Chennai: The News Minute; 2022 Dec 06 [cited 2025 Oct 23]. Available from:
https://www.thenewsminute.com/andhra-pradesh/ap-industries-find-it-easier-pay-compensation-implement-safety-protocols-170639
139. Chemical Plant Explosion Attributed to Lack of Qualified Staff and Cooling System: Preliminary Report [Internet]. JOIFF; 2024 Jul 19 [cited 2025 Oct 28]. Available from:
https://www.joiff.com/chemical-plant-explosion-attributed-to-lack-of-qualified-staff-and-cooling-system-preliminary-report
140. Joint Committee (NGT OA No. 106/2020). Report of the Joint Committee in the matter of OA No. 106/2020 [Internet]. New Delhi: National Green Tribunal; 2020 Jul 06 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/NGT/REPORT2-31.12.2020.pdf
141. Ghahramani A, Amirbahmani A. A study of the causes of occupational accidents in manufacturing companies [Internet]. Urmia (Iran): Urmia University of Medical Sciences, Social Determinants of Health Research Center; 2020 [cited 2025 Oct 28]. Available from:
https://archtrauma.kaums.ac.ir/article_156947.html
142. The Times of India. Poor inspection of hazardous factories raises safety concerns in Andhra Pradesh [Internet]. New Delhi: The Times of India; 2025 Sep 02 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/vijayawada/poor-inspection-of-hazardous-factories-raises-safety-concerns-in-andhra-pradesh/articleshow/123640012.cms
143. James TC. Bulk drug industry in India: challenges and prospects. New Delhi: Research and Information System for Developing Countries (RIS); 2020 Dec.
144. AMLEGALS. Implementation of labour laws in Special Economic Zones. Ahmedabad: AMLEGALS; 2025 Jul 21.
145. Mansingh P, Eluri S, Sreejesh NP. Trade unions and Special Economic Zones in India. New Delhi: Centre for Education and Communication (CEC) for ILO Bureau for Workers’ Activities; [no date].
146. Virtuosity Legal. Workers’ rights in SEZs in India: a legal perspective on exploitation and protection mechanisms. 2025 Aug 9 (issue Jul 2025).
147. National Green Tribunal (Principal Bench, New Delhi). Original Application No. 106/2020 (with reports dated 2020 Oct 26 and 2020 Nov 23) [Internet]. New Delhi: National Green Tribunal; 2020 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/ngt-court-cases/
2. Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. Guidelines for the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India. New Delhi: Government of India; 2020 Oct 29.
3. Guidelines of the Scheme "Promotion of Bulk Drug Parks", Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals; 27th July, 2020
4. Indian Bulk Drug Industry: Regaining Lost Glory. [Internet]. New Delhi: Confederation of Indian Industry (CII); 2017 [cited 2025 Nov 11]. Available from: https://ciipharma.in/pdf/API-Report-2017.pdf
5. Indian API Industry: Reaching the Full Potential. [Internet]. New Delhi: Confederation of Indian Industry (CII); 2020 [cited 2025 Nov 04]. Available from: https://www.medicpresents.com/medicfiles/4d15_65793.indianapiindustryreachingthefullpotentialkpmgciithoughtleadershipreport2020.pdf
6. Sandhu G. Making India self-sufficient. Express Pharma [Internet]. Mumbai: Express Pharma; 2020 Aug 28 [cited 2025 Oct 25]. Available from:
https://www.expresspharma.in/making-india-self-sufficient/
7. Shefali Singh and Harvinder Popli, Indian Active Pharmaceutical Ingredient (API) Industry—An overview on Challenges, Opportunities and Regulatory prerequisites. International Journal of Drug Regulatory Affairs, 2021; 9(2):66–76.
8. Salient Features of the recommendations of the Katoch committee Report on Active Pharmaceuticals Ingredients (APIs), Ministry of Chemicals and Fertilizers Department of Pharmaceuticals, New Delhi; 24th September, 2015.
9. The Special Economic Zones Act, 2005 (Act No. 28 of 2005), Amended upto April 2024, Export Promotion Council for EOUs and SEZs, Ministry of Commerce and Industry[Internet]. Government of India, New Delhi, 2005 [cited 2025 Nov 04]. Available from:
https://epces.in/uploads/the-special-economic-act-text.pdf.
10. Government of India. The Special Economic Zones Rules, 2006 [Internet]. New Delhi: Ministry of Commerce and Industry, 2006 [cited 2025 Nov 04]. Available from:
https://epces.in/uploads/the-special-economic-zones-rules-text.pdf,
11. Policy framework for Special Economic Zones (SEZs) in Andhra Pradesh, Industries and Commerce Department; G.O.Ms.No.151;2002. Apr 09.
12. Labour Department – Ease of doing business – Introduction of online inspection system, Government of Andhra Pradesh, Abstract; 2016 May 31.
13. Online Consent Management and Monitoring System[Internet]. MEFCC, Government of India [cited 2025 Oct 26]. Available from:
https://ocmms.nic.in/OCMMS_NEW/
14. Andhra Pradesh Pollution Control Board (APPCB). Online Consent Management and Monitoring System (OCMMS) Portal [Internet]. Vijayawada: APPCB; [cited 2025 Oct 25]. Available from: https://apocmms.nic.in/APPCB/
15. The Andhra Pradesh Single Desk Policy 2015 – Modified Policy - GOVERNMENT OF ANDHRA PRADESH ABSTRACT; 2016 Jun 14.
16. Industrial Policy Framework for the State of Telangana, Industries and Commerce Department [Internet]. Government of Telangana; 2014 [cited 2025 Oct 27]. Available from:
https://startup.telangana.gov.in/wp-content/uploads/2025/02/Industrial-Framework-2014-Version-1-1.pdf.
17. Industrial Policy Framework For The State of Telangana[Internet]. [cited 2025 Oct 27]. Available from:
https://www.tgiic.telangana.gov.in/filePreview/custom/Industrail%20policy%20Framework%20for%20the%20state?fileName=CMS/File_080720241203051120401271.Industrail%20policy%20Framework%20for%20the%20state.pdf
18. The Telangana State Industrial Project Approval and Self Certification System (TS iPASS) Act,2014 [Internet]. Act3 of 2014[cited 2025 Oct 27]. Available from:
https://www.casemine.com/act/in/5ed4fb14894ef23297d8bdf5.
19. Labour, Employment, Training and Factories Department – Inspections under various Labour Laws to facilitate Ease of Doing Business in the State, LABOUR EMPLOYMENT TRAINING and FACTORIES (LABOUR) DEPARTMENT G.O.Ms. No. 7; 2017 Apr 21.
20. Industrial and Commerce Department- Ease of Doing Business (EODB)-Business Reform Action Plan -2017-Central inspection system – orders- issued, INDUSTRIES and COMMERCE (IP and INF) DEPARMENT G.O.Ms.No. 45 1; 2017 Jul20.
21. Telangana Pollution Control Board[Internet]. [cited 2025 Oct 27]. Available from:
https://tgpcb.cgg.gov.in/?menuid=1001,
22. Central Pollution Control Board (CPCB). National OCMMS Dashboard Listing State Pollution Control Board Online Consent Portals, New Delhi: CPCB. [Cited 2025 Oct 27]. Available from: https://cpcb.nic.in/.,
23. Driving Sustainable Growth,AurobindoPharma Ltd. Integrated Annual Report 2023–24: Hyderabad: Aurobindo Pharma Ltd; 2024. p. 230.
24. Aurobindo Pharma Ltd. Business Responsibility and Sustainability Report for FY 2023–24. Mumbai: Submitted to National Stock Exchange of India Ltd; 2024. p. 5, 16–18, 26–27.
25. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation to M/s Aurobindo Pharma Ltd, Unit XIV, Plot No 17 E, Bonangi Village, JN Pharma City, Parawada, Visakhapatnam Dist, Andhra Pradesh 531019 (7-5/2013/EU/WC-0461), 2023 Sep 18.
26. Government of India, MoEF, Environmental Clearance No. J-12011/1/2004-IA (CIE), MoEF; 2005 Mar 10.
27. CDSCO WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in Various States – List for Andhra Pradesh (No. 51), CDSCO; 2022 Dec.
28. USFDA Inspection Report – Aurobindo Pharma Ltd Unit XIV Anakapalli Dist Andhra Pradesh; 2023 Jul 18. Silver Spring (MD): USFDA; 2023.
29. Aurobindo Pharma Ltd. Completion of US FDA Inspection at Unit XIV – Intimation to National Stock Exchange of India Ltd; 2023 May 19. Hyderabad: Aurobindo Pharma Ltd; 2023.
30. CPCB, Directions under Section 5 of the Environment (Protection) Act 1986 – Show-Cause Notice to M/s Aurobindo Pharma Ltd Unit XIV Plot No 17A JN Pharma City Parawada Visakhapatnam AP; 2021 Jun 22. New Delhi: CPCB; 2021.
31. Aurobindo Pharma Ltd. Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 – Intimation regarding Workplace safety Accident on 6 Apr 2024 at Unit 6 of Apitoria Pharma Pvt Ltd (Wholly Owned Subsidiary). Hyderabad: Aurobindo Pharma Ltd; 2024 Apr 7.
32. The Times of India. Gas leak explosion in pharma units: 2 dead, 6 injured [Internet]. New Delhi: The Times of India; 2024 Apr 08 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/gas-leak-explosion-in-pharma-units-2-died-6-injured/articleshow/109116029.cms
33. The Hindu. Apitoria Pharma hikes workers’ wages [Internet]. Chennai: The Hindu; 2024 Jun 27 [cited 2025 Oct 27]. Available from:
https://www.thehindu.com/news/national/andhra-pradesh/apitoria-pharma-limited-hikes-workers-wages/article68340274.ece
34. Impacts of Pharmaceutical Pollution on Communities and Environment in India [Internet]. London: Changing Markets Foundation and Ecostorm; [cited 2025 Oct 27]. Available from:
https://changingmarkets.org/report/impacts-of-pharmaceutical-pollution-on-communities-and-environment-in-india/
35. Hyderabad’s Pharmaceutical Pollution Crisis [Internet]. London: Changing Markets Foundation; 2018 Jan [cited 2025 Oct 27]. Available from:
https://changingmarkets.org/report/hyderabads-pharmaceutical-pollution-crisis/
36. Annual Report 2022–23, Gland Pharma Ltd.: Strengthening Our Core amid Challenges. Hyderabad: Gland Pharma Ltd; 2023.
37. Annual Report 2021–22: Manufacturing Excellence – Robust R and D – Quality First – Best-in-Class Products – Regulatory Compliance Gland Pharma Ltd. Hyderabad: Gland Pharma Ltd; 2022.
38. Gland Pharma Ltd. Business Responsibility and Sustainability Report 2023–24 [Internet]. Hyderabad: Gland Pharma Ltd; 2024 [cited 2025 Nov 04]. Available from: https://glandpharma.com/images/BRSR%20FY%202023-24.pdf
39. Gland Pharma facility in Vizag receives EIR from US FDA [Internet]. Chennai: The Hindu; [cited 2025 Oct 27]. Available from: https://www.thehindu.com/business/gland-pharma-facility-in-vizag-recieves-eir-from-us-fda/article69731760.ece
40. WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in various states of India [Internet]. New Delhi: CDSCO; 2019 May [cited 2025 Oct 27]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadIndustryCommon/listwhogmp.pdf
41. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation 7-5/12018/EU/WC-0427 to M/s Gland Pharma Ltd Plot Nos 49 and 50 JN Pharma City Parawada Visakhapatnam 531019 AP; 2023 Jun 22. New Delhi: CDSCO; 2023.
42. Government of India, MoEFC Environmental Clearance F. No. J-11011/265/2015-IA II (1). New Delhi: MoEFCC; 2019 Jan 2.
43. CONDITION-WISE COMPLIANCE REPORT OF ENVIRONMENTAL CLEARANCE MoEF, Govt. of India EC Order No.: J-11011/265/2015-IA II (I), dated 02-01-2019
44. Andhra Pradesh Pollution Control Board (APPCB). Consent Order No. APPCB/VIA/VIA/14347/HO/CFO/ 2019 [Internet]. Vijayawada: APPCB; 2019 Sep 17 [cited 2025 Nov 06]. Available from:
https://pcb.ap.gov.in/APPCBDOCS/Tenders_Noti/7.%20DS%20-%20Amendment%20-%20Porus%20Laboratories%20Pvt%20Ltd,%20Unit%20%E2%80%93%20IV,%20Krishna%20District.pdf
45. Porus Laboratories Pvt Ltd. Proposed Expansion of APIs and API Intermediates Manufacturing Unit with 3 MW Captive Power Plant at Akkireddigudem (MusunuruMandal), Plan dated 2016 Jan 25. Eluru: Porus Labs; 2016.
46. Porus Laboratories Pvt Ltd. Proposed Expansion Project of Active Pharmaceutical Ingredients and API Intermediates Manufacturing Unit with R and D Facility and 3 MW Coal/Husk/Pellet-Fired Captive Power Plant at Akkireddigudem (V), Musunuru (M), Krishna Dist; 2018 Mar 13. Eluru: Porus Labs; 2018.
47. Porus Laboratories Pvt Ltd. Risk Assessment Report Part B – Chapter 7 of EIA Report (Unit IV). Eluru: Porus Labs; 2018.
48. NGT Judgment on Porus Labs Accident (CaseMine Digest) [Internet]. New Delhi: National Green Tribunal Southern Zone; 2022 Sep 21 [cited 2025 Nov 06]. Available from: https://www.legitquest.com/case/aryavart-foundation-v-porus-laboratories-private-limited/739401
49. Muttevi S. Porus Labs was a ticking time bomb for Akkireddygudem village. The New Indian Express [Internet]. Chennai: The New Indian Express; 2022 Apr 18 [cited 2025 Oct 22]. Available from: [insert URL]
50. NGT slaps Rs 29 lakh penalty on Porus Labs [Internet]. Chennai: The New Indian Express; 2022 Sep 25 [cited 2025 Nov 11]. Available from: https://www.newindianexpress.com/states/andhra-pradesh/2022/Sep/24/ngt-slaps-rs-29-lakh-penalty-on-porus-labs-2501694.html
51. Pandey A. Porus Lab in Andhra Pradesh shut after six workers died in fire accident [Internet]. Noida: India Today; 2022 Apr 15 [cited 2025 Oct 27]. Available from: https://www.indiatoday.in/india/story/andhra-pradesh-pollution-control-board-shut-down-porus-lab-after-workers-died-fire-accident-1937717-2022-04-15
52. World Health Organization. Prequalification Unit – Public Inspection Report (WHOPIR): Desk Assessment of API Manufacturer, Hetero Infrastructure SEZ Ltd, Unit IX [Internet]. Geneva: WHO; [cited 2025 Oct 27]. Available from:
https://extranet.who.int/prequal/medicines/ha696
53. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation to M/s Hetero Drugs Ltd (Unit IX) Plot No 1 Hetero Infrastructure SEZ Ltd N. Narasapuram Village Nakkapalli Mandal Visakhapatnam Dist (AP) 75/2013/EU/WC-0066; 2019 Sep 3. New Delhi: CDSCO; 2019.
54. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation 7-5/2013/EU/WC-0065 to M/s Hetero Labs Ltd (Unit IX) Plot No 2 Hetero Infrastructure SEZ Ltd N. Narasapuram Village Nakkapalli Mandal Anakapalli Dist AP 531081; 2023 Jun 23. New Delhi: CDSCO; 2023.
55. Hetero Drugs Ltd. Compliance report of Environmental Clearance from Hetero Drugs Ltd Unit VI [Internet]. Hyderabad: Hetero Drugs Ltd; 2012 Sep 10 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HDL-VI_EC_Compliance_June_status_report.pdf
56. Hetero Labs Ltd. Environment Clearance No. J-11011/398/2010-IA-II dated 2012 Sep 10 – Compliance report [Internet]. Hyderabad: Hetero Labs Ltd; 2022 Dec 29 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HDL-VI-EC-Compliance-2022.pdf
57. Hetero Labs Ltd. Environment Clearance No. J-11011/398/2010-IA-II dated 2012 Sep 10 – Compliance report [Internet]. Hyderabad: Hetero Labs Ltd; 2023 May 13 [cited 2025 Nov 06]. Available from:
https://www.hetero.com/pdf/HLL-III(HDL-VI)-EC-Compliance-June2024.pdf
58. Hetero Labs. The Promise of a Healthier World: Sustainability Report 2020–21 [Internet]. Hyderabad: Hetero Labs; 2021 [cited 2025 Oct 27]. Available from:
https://www.hetero.com/pdf/Hetero_Sustainability_Report_%28202021%29.pdf
59. Hetero Labs. Fostering Sustainability for Posterity: Sustainability Report 2021–22 [Internet]. Hyderabad: Hetero Labs; 2022 [cited 2025 Oct 27]. Available from:
https://www.hetero.com/pdf/Hetero%20%20Sustainability%20Report%20%282021-22%29%20-%205%20May%2023%20%28web%20version%29.pdf
60. Hetero Labs Ltd. Six-Monthly Compliance Report Submitted to Ministry of Environment Forest and Climate Change, Vijayawada; 2023 Dec 1. Vijayawada: Hetero Labs; 2023.
61. Hetero Labs Ltd. Certified Third-Party Six-Monthly Compliance Report for Environmental Clearance No. J-11011/396/2010-IA II (I) dated 2012 Sep 10; submitted to MoEFCC Chennai; 2022 Jan 20. 2022.
62. Another disaster in Andhra raises fresh questions on industrial safety [Internet]. Mumbai: Business Standard; 2022 Apr 14 [cited 2025 Nov 11]. Available from:
https://www.business-standard.com/article/current-affairs/another-disaster-in-andhra-raises-fresh-questions-on-industrial-safety-122041400917_1.html
63. Blast at Hetero Drugs Nakkapalli kills two [Internet]. New Delhi: Business Today; 2013 Jan 05 [cited 2025 Oct 27]. Available from:
https://www.businesstoday.in/latest/corporate/story/blast-at-hetero-drugs-nakkapalli-unit-two-killed-39312-2013-01-05
64. Hetero Drugs DGM held for blast [Internet]. New Delhi: The Times of India; 2013 Mar [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/hetero-drugs-dgm-held-for-reactor-blast/articleshow/18757091.cms
65. One worker killed in explosion at Hetero Drugs scrap yard [Internet]. Chennai: The New Indian Express; 2016 Jun 23 [cited 2025 Oct 27]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2016/Jun/22/one-worker-killed-in-explosion-at-hetero-drugs-scrap-yard-884018.html
66. Visakhapatnam: Two employees seriously injured in Hetero Pharma blast [Internet]. New Delhi: The Times of India; 2022 Feb 23 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/visakhapatnam-two-employees-seriously-injured-in-hetero-pharma-blast/articleshow/89781623.cms
67. MD Bureau. One dies in Hetero Visakhapatnam Plant Blast [Internet]. New Delhi: Medical Dialogues; 2022 Feb 25 [cited 2025 Oct 27]. Available from:
https://medicaldialogues.in/news/industry/pharma/one-dies-in-hetero-visakhapatnam-plant-blast-89134
68. Anakapalli: 12 workers hospitalised after toxic gas leak at Hetero Pharma [Internet]. New Delhi: The Times of India; 2025 Feb 05 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/vijayawada/12-workers-hospitalized-after-inhaling-fumes-in-a-pharma-company-in-andhra-pradeshs-anakapalle/articleshow/117931598.cms
69. Government of India, Ministry of Environment, Forest and Climate Change. Reply affidavit on behalf of MoEFCC before the National Green Tribunal Southern Zone Bench, Chennai [Internet]. New Delhi: MoEFCC; 2023 [cited 2025 Oct 27]. Available from:
https://www.greentribunal.gov.in/sites/default/files/news_updates/OA%2023%20of%202022%20Response%20by%20R11.pdf
70. CDSCO (International Cell). Written Confirmation No. 7-5/2021/EU/WC-0501 dated 2022 Jun 15 [Internet]. New Delhi: CDSCO; 2022 [cited 2025 Oct 27]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadInternationalCell/WC%20-0094%20-Hikal%20%282%29.pdf
71. CDSCO (International Cell). Written Confirmation No. 7-5/2021/EU/WC-0501 dated 2024 May 16 [Internet]. New Delhi: CDSCO; 2024 [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadInternationalCell/WC%20-0501%20-Escientia.pdf
72. US Food and Drug Administration (USFDA). Drug Establishments Current Registration Site – Facilities List (as of April 30, 2024) [Internet]. Silver Spring (MD): USFDA; 2024 Apr 30 [cited 2025 Oct 27]. Available from:
https://www.fda.gov/media/178556/download
73. Government of India, Ministry of Environment and Forests. Environmental Clearance F. No. 21-379/2007-IA III for Multi-product Andhra Pradesh Special Economic Zone (APSEZ) [Internet]. New Delhi: MoEF; 2012 Feb 13 [cited 2025 Oct 27]. Available from:
https://environmentclearance.nic.in/
74. Government of Andhra Pradesh. Initial Environmental Examination for Asian Development Bank (ADB) Projects [Internet]. Amaravati: Government of Andhra Pradesh; 2022 Dec [cited 2025 Oct 28]. Available from:
https://ewsdata.rightsindevelopment.org/files/documents/04/ADB-48434-004_9wZhbBp.pdf
75. Andhra Pradesh Pollution Control Board (APPCB). Consent to Operate (CTO), File No. APPCB-11022/182/2018-TEC-CFO-APPCB [Internet]. Vijayawada: APPCB; 2024 Jan 09 [cited 2025 Oct 28]. Available from:
https://www.ocmms.nic.in/OCMMS_NEW/download.action
76. US Food and Drug Administration (USFDA). Establishment inspection record—Escentia; status: NAI (No Action Indicated) [Internet]. Silver Spring (MD): USFDA; 2019 Aug 11 [cited 2025 Oct 28]. Available from:
https://hbw.citeline.com/-/media/supporting-documents/pink-sheet/2021/02/fda-drug-quality-inspections-fy-2020.pdf
77. Explosion claims 17 lives in Atchutapuram SEZ [Internet]. Vijayawada: The Pioneer; 2024 Aug 22 [cited 2025 Oct 27]. Available from:
https://www.dailypioneer.com/uploads/2024/epaper/august/vijayawada-english-edition-2024-08-22.pdf
78. Explosion at Andhra factory that killed 17 caused by inflammable solvent leakage [Internet]. New Delhi: Hindustan Times; 2024 Aug 22 [cited 2025 Nov 11]. Available from:
https://www.hindustantimes.com/india-news/explosion-at-andhra-factory-which-killed-17-caused-by-inflammable-solvent-leakage-101724331154090.html
79. Bhattachargee S. AP pharma unit blast: Officials find key design faults in plant [Internet]. Chennai: The Hindu; 2024 Aug 24 [cited 2025 Oct 28]. Available from:
https://www.thehindu.com/news/cities/Visakhapatnam/ap-pharma-unit-blast-officials-find-key-design-faults-in-plant/article68562041.ece
80. Raghavendra V. High-level committee report on accident at pharma company in Anakapalli district ‘deficient’, allege retired scientists [Internet]. Vijayawada: The Hindu; 2025 Mar 24 [cited 2025 Oct 28]. Available from:
https://www.thehindu.com/news/national/andhra-pradesh/high-level-committee-report-on-accident-at-pharma-company-in-anakapalli-district-deficient-allege-retired-scientists/article69369348.ece
81. Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. Rajya Sabha Unstarred Question No. 315 answered on 2025 Jul 22 [Internet]. New Delhi: Government of India; 2025 Jul 22 [cited 2025 Oct 28]. Available from:
https://sansad.in/getFile/annex/268/AU315_UCXCGY.pdf
82. Central Pollution Control Board (CPCB). National Inventory on Generation and Management of Hazardous and Other Wastes (2022–23) [Internet]. New Delhi: CPCB; 2024 May [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/uploads/hwmd/Annual_Inventory2022-23.pdf
83. Central Pollution Control Board (CPCB). National Inventory on Generation and Management of Hazardous and Other Wastes (2023–24) [Internet]. New Delhi: CPCB; 2025 Apr [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/uploads/hwmd/Annual_Inventory2023-24.pdf
84. Siva G. Safety audit was done at Sahithi Pharma in April [Internet]. New Delhi: The Times of India; 2023 Jul 02 [cited 2025 Oct 27]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/safety-audit-was-done-at-sahithi-pharma-in-april/articleshow/101427015.cms
85. Five-member panel probes pharma unit blast in Andhra [Internet]. Chennai: The New Indian Express; 2023 Jul 02 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/andhra-pradesh/2023/Jul/02/five-member-panel-probes-pharma-unit-blast-in-andhra-2590617.html
86. Probe panel says non-technical staff was Sahiti unit in-charge [Internet]. Chennai: The New Indian Express; 2023 Jul 25 [cited 2025 Nov 02]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2023/Jul/25/probe-panel-says-non-technical-staff-was-sahiti-unit-in-charge-2598267.html
87. Andhra Pradesh Pollution Control Board (APPCB). Report filed before the Hon’ble National Green Tribunal, Southern Zone, Chennai—NGT stop order to Sahithi [Internet]. Vijayawada: APPCB; 2023 Aug 01 [cited 2025 Oct 28]. Available from:
https://www.scribd.com/document/697921812/8923-0
88. Kin of AP blast victims seek compensation [Internet]. Chennai: The New Indian Express; 2023 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/business/2023/Jul/01/kin-of-ap-blast-victims-seek-compensation-from-pharmaceutical-company-2590422.html
89. Rao GJ. Safety audit was done in 186 hazardous units of Andhra [Internet]. Chennai: The New Indian Express; 2023 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2023/Jul/01/safety-audit-done-in-186-hazardous-units-of-andhra-2590338.html
90. Samritan SG. Vizag to get off-site emergency plan amid industrial risks [Internet]. Hyderabad: Deccan Chronicle; 2024 Aug 29 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/southern-states/andhra-pradesh/vizag-to-get-off-site-emergency-plan-amid-industrial-risks-1819831
91. Andhra Pradesh Pollution Control Board (APPCB). Consent to Establish (CTE) Order No. 193/APPCB/CTE/RO-VSP/HO/2009, File No. 193/APPCB/CFE/RO-VSP/HO/2014 [Internet]. Vijayawada: APPCB; 2023 Mar 31 [cited 2025 Oct 28]. Available from:
https://ocmms.nic.in/OCMMS_NEW/download.action
92. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation No. 7-5/2016/EU/WC-0371 to M/s Sainor Life Sciences Pvt Ltd [Internet]. New Delhi: CDSCO; 2019 Oct 28 [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadAlertsFiles/23janUpdated%20Approved%20WC.pdf
93. WHO-GMP Certified Manufacturing Units for Certificate of Pharmaceutical Products (COPPs) in various states of India [Internet]. New Delhi: CDSCO; 2022 Dec [cited 2025 Oct 28]. Available from:
https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadIndustryCommon/22WHO%20GMP%20CoPP%20units.pdf
94. Andhra Pradesh Pollution Control Board (APPCB).Consent and Authorization Order, Consent Order No. 7223/ APPCB/ ZO-VSP/ VSP/ CFO/ 2020. Visakhapatnam: APPCB (Zonal Office); 2020 Sep 23.
95. Two dead, five injured in blast at Sainor Life Sciences unit [Internet]. New Delhi: The Times of India; 2015 Sep 29 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/2-dead-5-injured-in-blast-at-sainor-life-sciences-unit/articleshow/49147773.cms
96. Vizag pharma unit where gas leak killed two saw similar tragedy in 2015 [Internet]. Chennai: The News Minute; 2020 Jul 01 [cited 2025 Oct 28]. Available from:
https://www.thenewsminute.com/andhra-pradesh/vizag-pharma-unit-where-gas-leak-killed-two-saw-similar-tragedy-2015-127685
97. Joint Committee (NGT matter). Report of the Joint Committee submitted to the National Green Tribunal [Internet]. 2020 Jul 06 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/NGT/REPORT2-31.12.2020.pdf
98. Ministry of Environment, Forest and Climate Change (India). NGT directs that safety audits be conducted for the pharma city in Visakhapatnam along with other locations in the State. Environmental Law Newsletter [Internet]. 2020 Dec;1(4) [cited 2025 Oct 28]. Available from:
https://www.amsshardul.com/wp-content/uploads/2021/01/Environmental-Law-Newsletter-%E2%80%93-Issue-4.pdf
99. District Collector, Visakhapatnam. Report on gas leakage at Sainor Life Sciences, JN Pharmacity, Visakhapatnam [Internet]. Visakhapatnam: District Collectorate; [cited 2025 Oct 28]. Available from:
https://telugu.samayam.com/andhra-pradesh/news/vizag-collector-press-meet-on-sainor-life-sciences-factory-gas-leak-tragedy/articleshow/76770622.cms
100. Swedish report slams polluting pharma firms of Hyderabad, Vizag [Internet]. Hyderabad: Deccan Chronicle; 2016 Apr 20 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/current-affairs/200416/swedish-report-slams-polluting-pharma-firms-from-hyderabad-vizag.html
101. Human Rights Forum (HRF). Vizag Pharma City: A virtual death zone [Internet]. Hyderabad: HRF; 2020 Jun 30 [cited 2025 Oct 28]. Available from:
https://humanrightsforum.org/vizag-pharma-city-a-virtual-death-zone/
102. Accident at Sainor unit in Vizag more proof of companies bypassing rules [Internet]. New Delhi: Down To Earth; 2020 Jul 09 [cited 2025 Oct 28]. Available from:
https://www.downtoearth.org.in/pollution/accident-at-sainor-unit-in-vizag-more-proof-of-companies-bypassing-rules-72214
103. Synergene Active Ingredients Pvt Ltd. Infrastructure and regulatory—capacity 380 KL; employees 250; WHO-GMP, ISO 9001/14001/45001 [Internet]. Visakhapatnam: Synergene Active Ingredients Pvt Ltd; [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/infrastructure-and-regulatory/
104. Andhra Pradesh Pollution Control Board (APPCB). Consent Order No. APPCB/VSP/VSP/423/HO/CFO/2019; File No. APPCB-11022/64/2019-TEC-CFO-APPCB [Internet]. Vijayawada: APPCB; 2019 May 12 [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2021/03/unit-III-CFO.pdf
105. Andhra Pradesh Pollution Control Board (APPCB). Red Category Consent to Operate and Hazardous Waste Authorization Order, Consent Order No. APPCB/VSP/VSP/423/HO/CFO/2024 [Internet]. Vijayawada: APPCB; 2024 Jun 05 [cited 2025 Oct 28]. Available from:
https://ocmms.nic.in/OCMMS_NEW/download.action
106. Drugs Control Administration, Government of Andhra Pradesh. Good Manufacturing Practices and Good Laboratory Practices Certificate to M/s Synergene Active Ingredients Pvt Ltd, Unit III [Internet]. Visakhapatnam: Drugs Control Administration; 2025 Jan 29 [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2025/03/U-III-GMP-CERTIFICATE.pdf
107. Synergene Active Ingredients Pvt Ltd. Proposal to establish bulk drugs and intermediates manufacturing unit at Plot No. 59-A, JN Pharmacity, Parawada Mandal, Visakhapatnam District, Andhra Pradesh [Internet]. Visakhapatnam: Synergene Active Ingredients Pvt Ltd; [cited 2025 Oct 28]. Available from:
https://synergeneapi.com/wp-content/uploads/2021/03/unit-III-EMP.pdf
108. Fire erupts at pharmacy unit in Andhra’s Anakapalle; four hurt [Internet]. Chennai: The New Indian Express; 2024 Aug 23 [cited 2025 Oct 28]. Available from:
https://www.newindianexpress.com/states/andhra-pradesh/2024/Aug/23/four-injured-in-fire-mishap-at-pharma-factory-in-ap-2
109. Andhra Pradesh: Toll rises to three in Parwada pharma unit fire accident [Internet]. Hyderabad: Telangana Today; 2024 Aug 26 [cited 2025 Nov 11]. Available from:
https://telanganatoday.com/andhra-pradesh-toll-rises-to-three-in-parwada-pharma-unit-fire-accident
110. Nalla Babu. Pharma mishap: 2 more workers succumb, toll rises to three [Internet]. New Delhi: The Times of India; 2024 Aug 27 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/visakhapatnam/pharma-mishap-death-toll-rises-to-three-in-visakhapatnam/articleshow/112819858.cms
111. World Health Organization (WHO). Public Inspection Report: Laurus Labs Limited, Unit 3, Visakhapatnam, India (4–7 September 2017) [Internet]. Geneva: WHO; 2017 [cited 2025 Oct 28]. Available from:
https://extranet.who.int/prequal/sites/default/files/whopir_files/WHOPIR_Laurus04-07September2017.pdf
112. Laurus Labs Ltd. Creating Value, Sustaining Trust—Integrated Report 2021 [Internet]. Hyderabad: Laurus Labs Ltd; 2021 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/images/pdfs/LaurusIntegratedReport.pdf
113. Laurus Labs Ltd. Enhancing Capabilities Ensuring Future: Annual Report 2022–23 [Internet]. Hyderabad: Laurus Labs Ltd; 2023 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/pdf/LaurusLabsAnnualReportFY2022-23.pdf
114. Consent for Establishment (CFE) Order No. 331/APPCB/CFE/RO-VSP/HO/2014 Andhra Pradesh Pollution Control Board (26 Dec 2019).
115. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation F. No. 7-5/2017/EU/WC-0395—Pharma City, Parawada (M), Visakhapatnam 531021, Andhra Pradesh. New Delhi: CDSCO; 2019 Mar 5.
116. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit 3), Plot No. 18, JN Pharmacity, Parawada, Visakhapatnam 531021, Andhra Pradesh; 75/2017/EU/WC-0395. New Delhi: CDSCO; 2020 Dec 4.
117. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit 3), Plot No. 18, JN Pharmacity, Parawada, Visakhapatnam 531021, Andhra Pradesh; 7-5/2017/EU/WC-0395. New Delhi: CDSCO; 2022 Aug 1.
118. Government of India, Directorate General of Health Services, CDSCO (International Cell). Written Confirmation—M/s Laurus Labs Ltd (Unit-III), Plot No. 18, JN Pharmacity, ParawadaMandal, Anakapalli District 531021, Andhra Pradesh; 7-5/2017/EU/WC-0395. New Delhi: CDSCO; 2024 Apr 8.
119. World Health Organization (WHO). Prequalification Unit—Public Inspection Report (WHOPIR): Desk Assessment of Active Pharmaceutical Ingredient (API) Manufacturer. Geneva: WHO; 2020 Jun 3.
120. Laurus Labs Ltd. Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015—EIR received. Hyderabad: Laurus Labs Ltd; [year unknown].
121. Laurus Labs Ltd. Business Responsibility and Sustainability Report—Annual Report 2023–24 [Internet]. Hyderabad: Laurus Labs Ltd; 2024 [cited 2025 Oct 28]. Available from:
https://nsearchives.nseindia.com/corporate/LAURUSLABS_01102024194544_BRSR2024.pdf
122. Laurus Labs Ltd. Fulfilling Our Commitment to Global Wellbeing [Internet]. Hyderabad: Laurus Labs Ltd; [cited 2025 Oct 28]. Available from: https://lauruslabs.com/
123. Deccan Chronicle. Four dead, one hurt in Vizag Pharma City fire mishap [Internet]. Hyderabad: Deccan Chronicle; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/in-other-news/261222/4-dead-one-hurtin-vizag-pharma-city-fire-mishap.html
124. Laurus Labs Ltd. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 [Internet]. Mumbai: BSE Ltd; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.lauruslabs.com/Investors/PDF/Disclosures/SEIntimation.pdf
125. Deccan Chronicle. Four dead, one hurt in Vizag Pharma City fire mishap [Internet]. Hyderabad: Deccan Chronicle; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/nation/in-other-news/261222/4-dead-one-hurtin-vizag-pharma-city-fire-mishap.html
126. Reuters. India’s Laurus Labs says four employees died in fire incident [Internet]. London: Reuters; 2022 Dec 27 [cited 2025 Oct 28]. Available from:
https://www.reuters.com/world/india/indias-laurus-labs-says-four-employees-dead-after-fire-incident-2022-12-27/
127. Telangana State Pollution Control Board (TSPCB). List of industries under consent management in Medak District [Internet]. Hyderabad: TSPCB; [cited 2025 Oct 28]. Available from:
https://tgpcb.cgg.gov.in/Uploads/AboutUs/Sangareddy.pdf
128. State Environment Impact Assessment Authority (SEIAA), Telangana. Proceedings of the 91st SEIAA Meeting [Internet]. Hyderabad: SEIAA Telangana; 2020 Dec 17 [cited 2025 Oct 28]. Available from:
https://environmentclearance.nic.in/report/minutes_meeting_report_b.aspx?state_id=38
129. SB Organics Ltd. Proposal for production of intermediates [Internet]. Hyderabad: SB Organics Ltd; [cited 2025 Oct 28]. Available from:
https://environmentclearance.nic.in/DownloadPfdFile.aspx
130. Business Standard. Explosion at Telangana pharma plant kills director, three workers; 16 injured [Internet]. Mumbai: Business Standard; 2024 Apr 03 [cited 2025 Oct 28]. Available from:
https://www.business-standard.com/india-news/explosion-at-telangana-pharma-plant-kills-director-3-workers-16-injured-124040301207_1.html
131. Deccan Chronicle. Telangana: Panel slams SBOL firm for deadly blast [Internet]. Hyderabad: Deccan Chronicle; 2024 Jul 21 [cited 2025 Oct 28]. Available from:
https://www.deccanchronicle.com/southern-states/telangana-panel-slams-sbol-firm-for-deadly-blast-1811419
132. Three months on, pharma unit blast probe still in limbo [Internet]. New Delhi: The Times of India; 2024 Jul 22 [cited 2025 Nov 11]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/3-months-on-pharma-unit-blast-probe-still-in-limbo/articleshow/111911195.cms
133. The Times of India. Lack of workplace safety norms, PCB nod to blame for pharma unit blast [Internet]. New Delhi: The Times of India; 2024 Apr 27 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/hyderabad/lack-of-safety-norms-pcb-nod-to-blame-for-pharma-unit-blast/articleshow/109636982.cms
134. The Economic Times. PCB levies Rs 31 lakh penalty on pharma manufacturing unit over violations [Internet]. Mumbai: The Economic Times; 2024 Dec 10 [cited 2025 Oct 28]. Available from:
https://manufacturing.economictimes.indiatimes.com/amp/news/life-sciences/pcb-levies-rs-31-lakh-penalty-on-pharma-manufacturing-unit-over-violations/116158889
135. Before the National Green Tribunal, Southern Zone, Chennai. Case order [Internet]. Chennai: National Green Tribunal; 2025 Feb 12 [cited 2025 Oct 28]. Available from: CaseMine database.
136. Government of India, Ministry of Health and Family Welfare. Lok Sabha Unstarred Question No. 2226 answered on 2025 Aug 1. New Delhi: Government of India; 2025 Aug 1.
137. Government of India, Ministry of Labour and Employment. Lok Sabha Unstarred Question No. 2416 to be answered on 2025 Aug 4. New Delhi: Government of India; 2025 Aug 4.
138. The News Minute. AP: Industries find it easier to pay compensation than implement safety protocols [Internet]. Chennai: The News Minute; 2022 Dec 06 [cited 2025 Oct 23]. Available from:
https://www.thenewsminute.com/andhra-pradesh/ap-industries-find-it-easier-pay-compensation-implement-safety-protocols-170639
139. Chemical Plant Explosion Attributed to Lack of Qualified Staff and Cooling System: Preliminary Report [Internet]. JOIFF; 2024 Jul 19 [cited 2025 Oct 28]. Available from:
https://www.joiff.com/chemical-plant-explosion-attributed-to-lack-of-qualified-staff-and-cooling-system-preliminary-report
140. Joint Committee (NGT OA No. 106/2020). Report of the Joint Committee in the matter of OA No. 106/2020 [Internet]. New Delhi: National Green Tribunal; 2020 Jul 06 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/NGT/REPORT2-31.12.2020.pdf
141. Ghahramani A, Amirbahmani A. A study of the causes of occupational accidents in manufacturing companies [Internet]. Urmia (Iran): Urmia University of Medical Sciences, Social Determinants of Health Research Center; 2020 [cited 2025 Oct 28]. Available from:
https://archtrauma.kaums.ac.ir/article_156947.html
142. The Times of India. Poor inspection of hazardous factories raises safety concerns in Andhra Pradesh [Internet]. New Delhi: The Times of India; 2025 Sep 02 [cited 2025 Oct 28]. Available from:
https://timesofindia.indiatimes.com/city/vijayawada/poor-inspection-of-hazardous-factories-raises-safety-concerns-in-andhra-pradesh/articleshow/123640012.cms
143. James TC. Bulk drug industry in India: challenges and prospects. New Delhi: Research and Information System for Developing Countries (RIS); 2020 Dec.
144. AMLEGALS. Implementation of labour laws in Special Economic Zones. Ahmedabad: AMLEGALS; 2025 Jul 21.
145. Mansingh P, Eluri S, Sreejesh NP. Trade unions and Special Economic Zones in India. New Delhi: Centre for Education and Communication (CEC) for ILO Bureau for Workers’ Activities; [no date].
146. Virtuosity Legal. Workers’ rights in SEZs in India: a legal perspective on exploitation and protection mechanisms. 2025 Aug 9 (issue Jul 2025).
147. National Green Tribunal (Principal Bench, New Delhi). Original Application No. 106/2020 (with reports dated 2020 Oct 26 and 2020 Nov 23) [Internet]. New Delhi: National Green Tribunal; 2020 [cited 2025 Oct 28]. Available from:
https://cpcb.nic.in/ngt-court-cases/
Statistics
53 Views | 64 Downloads
How to Cite
1.
Jayanti VR, Mandavilli SR, Battu H. An Analytical Study of Selected Bulk Drug Manufacturers in Andhra Pradesh and Telangana: SEZ Status, Regulatory Framework, Compliance, Oversight, and Workforce Welfare and Safety. Int J Drug Reg Affairs [Internet]. 2026Jun.15 [cited 2026Jul.10];14(2):60-5. Available from: https://www.ijdra.com/index.php/journal/article/view/906
Section
Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
